LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Therapeutic exploitation of ferroptosis.

Walravens, Magali / Koeken, Ine / Vanden Berghe, Tom

Biochemical Society transactions

2024  Band 52, Heft 2, Seite(n) 693–706

Abstract: Pathological breakdown of membrane lipids through excessive lipid peroxidation (LPO) was first described in the mid-20th century and is now recognized as a form of regulated cell death, dubbed ferroptosis. Accumulating evidence unveils how metabolic ... ...

Abstract Pathological breakdown of membrane lipids through excessive lipid peroxidation (LPO) was first described in the mid-20th century and is now recognized as a form of regulated cell death, dubbed ferroptosis. Accumulating evidence unveils how metabolic regulation restrains peroxidation of phospholipids within cellular membranes, thereby impeding ferroptosis execution. Unleashing these metabolic breaks is currently therapeutically explored to sensitize cancers to ferroptosis inducing anti-cancer therapies. Reversely, these natural ferroptotic defense mechanisms can fail resulting in pathological conditions or diseases such as ischemia-reperfusion injury, multi-organ dysfunction, stroke, infarction, or neurodegenerative diseases. This minireview outlines current ferroptosis-inducing anti-cancer strategies and highlights the detection as well as the therapeutic targeting of ferroptosis in preclinical experimental settings. Herein, we also briefly summarize observations related to LPO, iron and redox deregulation in patients that might hint towards ferroptosis as a contributing factor.
Mesh-Begriff(e) Ferroptosis ; Humans ; Lipid Peroxidation ; Neoplasms/metabolism ; Neoplasms/drug therapy ; Animals ; Iron/metabolism ; Oxidation-Reduction ; Antineoplastic Agents/therapeutic use ; Reperfusion Injury/metabolism ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/drug therapy
Chemische Substanzen Iron (E1UOL152H7) ; Antineoplastic Agents
Sprache Englisch
Erscheinungsdatum 2024-04-17
Erscheinungsland England
Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
ZDB-ID 184237-7
ISSN 1470-8752 ; 0300-5127
ISSN (online) 1470-8752
ISSN 0300-5127
DOI 10.1042/BST20230550
Signatur
Zs.A 944: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang